California Healthcare Institute (CHI)
1020 Prospect Street
About California Healthcare Institute (CHI)
CHI is a non-profit public policy research organization, representing leading California academic institutions, biotechnology, medical device, diagnostics, and pharmaceutical firms. As an influential advocate in California, where health care trends happen first and policy decisions have national and global impact, CHI's mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. Working closely with policy makers in Washington D.C. and Sacramento, CHI strives to create a favorable climate for scientific discovery and medical innovation. The Institute conducts economic and public policy research, produces industry analyses, develops educational programs and formulates policy on behalf of the biomedical research community and the patients we serve.
David Gollaher, Ph.D., President & CEO
Molly Ingraham, Vice President Operations Ingraham@chi.org
Todd Gillenwater, Vice President Public Policy Gillenwater@chi.org
Nicole Beckstrand, Director Corporate Communication email@example.com
Last Updated: 09-17-2007
57 articles about California Healthcare Institute (CHI)
Gail Maderis, currently president and chief executive officer of South San Francisco-based Antiva Biosciences, has a rock-solid resume.
California Life Sciences Association (CLSA) Announces Growth and Expansion in the Bay Area
California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, today announced the opening of an expanded office and events center in San Francisco, which is home to many of the top life sciences companies in the state.
ContraVir Invited To Present CMX157 Data At CHI's Eleventh Annual Drug Discovery Chemistry Conference
Benitec Featured At CHI's "Discovery On Target" Conference
CHI Release: Diagnostics Industry Authorities Deliberate On LDT Regulatory Reform And PAMA At The Seventh Annual Next Generation Dx Summit
BayBio and CHI Merge, Making California Life Sciences Association the Largest Life Sciences Advocacy Group in U.S.
CHI Statement On Outcome Of AB 463
CHI Applauds Advancement Of 21st Century Cures Initiative
TRICON: CHI’s Molecular Medicine Tri-Conference Kicks Off Despite Holiday, Slowed Travel
California Healthcare Institute (CHI) And BayBio (Bay Area Bioscience Association) Will Combine To Become The California Biomedical Innovation Alliance
California Healthcare Institute (CHI) Releases Report Highlighting Public Impact Of Hepatitis C, Opportunities For Action In U.S.
California Healthcare Institute (CHI) Adds Five Industry Leaders To Its Board
California Healthcare Institute (CHI) Applauds Congresswoman Eshoo and Members of the California Delegation on Their Leadership on the FDA SOS Act
California Healthcare Institute (CHI) Issues Statement on Supreme Court Ruling on the Affordable Care Act
California Healthcare Institute (CHI) Antibiotic Discovery and Development Initiative to Combat Public Health Crisis, National Security Threat, Economic Burden
California Healthcare Institute (CHI) Launches Podcast Highlighting Cardiovascular Disease Research in California
California Healthcare Institute (CHI) Board Elects New Members
California Healthcare Institute (CHI) Biomedical Leaders Weigh in on the Future of Biomedical Innovation, Investment, Reimbursement and Patient Access
California Healthcare Institute (CHI) Board Elects New Member
California Healthcare Institute (CHI) Announces Panel Topics and Speakers for 2011 Annual Meeting